Skip to main content
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
603.58
-2.03 (-0.34%)
May 5, 2025, 4:00 PM EDT - Market closed

Regeneron Pharmaceuticals Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Net Product
7.28B 7.63B 7.48B 7.32B 7.17B 7.08B 6.93B 6.94B
Net Product Growth
1.57% 7.79% 7.98% 5.43% 3.59% 2.67% -24.47% -28.06%
Collaboration
6.32B 6.06B 5.82B 5.60B 5.39B 5.50B 5.72B 5.33B
Collaboration Growth
17.26% 10.08% 1.76% 4.99% 6.56% 11.99% 35.65% 25.76%
Other
480.00M 515.00M 548.10M 572.20M 537.00M 536.10M 451.30M 397.20M
Other Growth
-10.61% -3.94% 21.45% 44.06% 38.72% 46.84% 39.46% 17.38%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.